Skip to content
After unsuccessful attempts to lower Medicare Part D beneficiary cost-sharing, the Centers for Medicare & Medicaid Services (CMS) will finally wrap up a proposal […]
CMS will apply pharmacy price concessions at point of sale Read More »
While the war in Ukraine disrupts the world supply of fertilizers, biotechnology can offer help. Fertilizer prices are at an all-time high, up as
As fertilizer prices hit record highs worldwide, biotech offers help Read More »
In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the
I am BIO Podcast: Hope for Alzheimer’s Read More »
The United States Trade Representative (USTR) Special 301 Report on Intellectual Property and Protection and Enforcement, released last week, is encouraging for calling out
USTR puts China on Priority Watch List, but still supports waiving IP protection Read More »
Global biotechnology company BeiGene launched construction of its state-of-the-art manufacturing campus and clinical R&D center with a ground-breaking ceremony in Princeton West Innovation Park,
BeiGene building drug manufacturing and R&D center in N.J. Read More »
A man in Colorado tested positive for an H5 bird flu virus, marking the first recorded human infection in the United States of the
First U.S. case of human infected with bird flu reported in Colorado Read More »
A broad coalition of 77 companies and associations that are stakeholders in the aviation industry—including the Biotechnology Innovation Organization (BIO) and its member companies,
BIO, business community call for SAF tax incentives Read More »
In the United States, over 500 people lose a limb daily, the Amputee Coalition says, adding that the number of people living with limb
National Limb Loss and Limb Difference Awareness Month highlights risks and challenges Read More »
China’s proposed rules on human genetics resource (HGR) would significantly restrict how foreign entities are able to access and use Chinese HGR for global
BIO: China’s human genetic resources regulations could threaten global R&D Read More »
The Lyme disease vaccine candidate developed by Pfizer and Valneva was “found to be more immunogenic” in pediatric patients than in adults in a
Pfizer-Valneva Lyme vaccine shows promising results in children Read More »
